It has been shown that CD11b+ Gr1+ myeloid cells, which include neutrophils, macrophages and myeloid-derived suppressor cells, promote tumour progression independent of the adaptive immune system, and that these cells render tumours refractory to angiogenic blockade by VEGF antibodies 18. Here, VEGFA is linked to neoplasm.